Acuta Capital Partners, LLC Ampio Pharmaceuticals, Inc. Put Options Transaction History

Acuta Capital Partners, LLC

  • $98.8 Million
  • Q3 2024

Put Options

2 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q2 2018

Aug 15, 2018
SELL
$1.66 - $3.82 $539,500 - $1.24 Million
-325,000 Closed
0 $0
Q1 2018

May 15, 2018
BUY
$2.16 - $3.48 $702,000 - $1.13 Million
325,000 New
325,000 $1.11 Million

Others Institutions Holding AMPE

# of Institutions
1
Shares Held
96.6K
Call Options Held
0
Put Options Held
0
View Full List

About Ampio Pharmaceuticals, Inc.

AMPE Quotes by TradingView
  • Ticker AMPE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 226,287,008
  • Description
  • Ampio Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of immunomodulatory therapies for the treatment of pain from osteoarthritis in the United States. Its product pipeline includes AP-013, an intra-articular injection, which is in phase III clinical trial for the treatment of osteoarthritis of the knee; AP-017, an...
More about AMPE
Track This Portfolio

Track Acuta Capital Partners, LLC Portfolio

Follow Acuta Capital Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Acuta Capital Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Acuta Capital Partners, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email